• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Docosahexaenoic Acid Selectively Suppresses Oral Pathogens While Preserving Microbiome Stability

by
November 14, 2026
in Health
Reading Time: 3 mins read
0
Docosahexaenoic Acid Selectively Suppresses Oral Pathogens While Preserving Microbiome Stability

Docosahexaenoic Acid Selectively Suppresses Oral Pathogens While Preserving Microbiome Stability

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The oral microbiome represents one of the most complex microbial ecosystems in the human body, and maintaining its delicate balance is essential for preserving both oral and systemic health. Disruption of this microbial homeostasis can actively promote the progression of dental caries and periodontal disease. Currently, the clinical management of oral pathogens still relies predominantly on conventional antibiotics; however, escalating concerns surrounding antimicrobial resistance and medication safety in special populations have spurred the search for gentler, food-derived alternatives capable of targeted intervention. In a new study published in Acta Microbiologica Sinica, researchers demonstrated that docosahexaenoic acid, a dietary polyunsaturated fatty acid, exhibits species- and strain-dependent selective inhibitory effects against oral bacteria, suppressing specific pathogens while preserving overall community stability.

The investigation was conducted by a research team led by Jinfeng Wang from the College of Food Science and Nutritional Engineering at China Agricultural University, alongside researchers affiliated with the Institute of Microbiology at the Chinese Academy of Sciences. To evaluate the antibacterial properties of dietary fatty acids, the team tested four polyunsaturated fatty acids against five common oral bacterial species across both single-species and mixed-species cultures. Furthermore, the scientists designed an eight-day randomized, placebo-controlled human mouth-rinse intervention to evaluate clinical responses in vivo. Saliva specimens collected during the trial were analyzed through quantitative polymerase chain reaction assays and metagenomic sequencing to track shifts across microbial communities.

Laboratory experiments demonstrated that the antibacterial impact of polyunsaturated fatty acids on oral pathogens is characterized by pronounced species- and system-dependent heterogeneity. In single-species culture assessments, Streptococcus oralis, Streptococcus mutans, and Porphyromonas gingivalis proved to be relatively sensitive to docosahexaenoic acid exposure. In contrast, Fusobacterium nucleatum and Prevotella intermedia displayed marked tolerance under identical experimental conditions. When these microorganisms were examined together within mixed-species cultures, the investigators noted that the overall antibacterial effect was notably diminished compared to single-species tests, highlighting the significant influence of ecological interactions and community structure on bacterial susceptibility.

The eight-day randomized, placebo-controlled human mouth-rinse trial provided insight into how docosahexaenoic acid operates within a complex living oral ecosystem. Metagenomic sequencing showed that the mouth rinse did not significantly alter the composition of the oral microbiota at the broad phylum level, indicating that fundamental microbial community stability was successfully maintained throughout the intervention. However, the rinse produced selective modulations at the finer genus and species levels. Specifically, the relative abundance of the genera Neisseria and Porphyromonas increased, whereas the relative abundance of Prevotella decreased. In addition, dynamic monitoring across the intervention revealed a consistent downward trend in the abundance of Fusobacterium nucleatum.

To explore responses below the species threshold, the researchers performed strain-level analyses on oral bacteria isolated directly from human saliva samples, with a specific focus on Fusobacterium pseudoperiodonticum isolates. The team constructed a phylogenetic tree of the isolated strains and monitored the growth curves of ten distinct F. pseudoperiodonticum strains subjected to docosahexaenoic acid treatment. Screening and validation based on peak optical density inhibition rates at 600 nanometers confirmed notable divergence, separating isolates into distinct sensitive and tolerant categories. Subsequent whole-genome analysis indicated that this differential sensitivity was closely linked to genomic variations in genes governing lipid metabolism and the bacterial cell envelope, particularly lapB, pilE, and ftsZ. Saliva metagenomic data further supported this connection between specific tolerance-associated genes and bacterial survival under treatment.

“DHA selectively suppresses specific bacteria while maintaining the overall stability of the oral microbiota,” stated lead author Jinfeng Wang of China Agricultural University. The research team emphasized that the observed antibacterial action does not stem from simple, broad-spectrum antimicrobial destruction. Instead, the biological outcome reflects a combination of differential cellular responses among specific bacterial species and strains, alongside intricate ecological interactions occurring across the wider oral community. The investigators noted that such milder, selective modulation helps protect community equilibrium and could provide valuable foundational evidence for developing precise oral microbiome regulation strategies, particularly in clinical contexts where conventional antibiotic interventions pose safety concerns or heighten resistance risks.

Despite these encouraging observations, the study authors emphasized several key limitations in their experimental design. The human mouth-rinse trial was short in duration, lasting only eight days, and involved a small participant cohort, with saliva metagenomic samples being pooled rather than analyzed individually. Furthermore, the laboratory mixed-culture model remains a simplified representation of the natural human oral cavity. The team indicated that future research must test longer intervention periods, evaluate a broader variety of oral bacterial species, and functionally validate the specific genetic mechanisms identified in tolerant strains. The work received financial backing from the National Natural Science Foundation of China, the Pinduoduo-China Agricultural University Research Fund, and the 2115 Talent Development Program of China Agricultural University.

Subject of Research: Selective inhibitory effects of docosahexaenoic acid on oral bacteria

Article Title: Selective inhibitory effects of docosahexaenoic acid on oral bacteria

Article References: Selective inhibitory effects of docosahexaenoic acid on oral bacteria. Original publication (Bibliographic details unavailable.)

Image Credits: AI Generated

DOI: Not provided

Keywords: oral microbiome, docosahexaenoic acid, polyunsaturated fatty acids, mouth rinse, Fusobacterium pseudoperiodonticum, antimicrobial resistance, metagenomic sequencing, oral health, Selective, inhibitory, effects, docosahexaenoic

News Source: Morgan Morrow. (November 14, 2026). Docosahexaenoic Acid Selectively Suppresses Oral Pathogens While Preserving Microbiome Stability. Scienmag.

Tags: Antimicrobial ResistanceDocosahexaenoicdocosahexaenoic acideffectsFusobacterium pseudoperiodonticumInhibitorymetagenomic sequencingmouth rinseoral healthoral microbiomepolyunsaturated fatty acidsselective
Share12Tweet7Share2ShareShareShare1

Related Posts

7T MRI Feasibility Study Maps Diffuse Lipid Alterations in Multiple Sclerosis

7T MRI Feasibility Study Maps Diffuse Lipid Alterations in Multiple Sclerosis

November 17, 2026
Negative Pressure Therapy Linked to Shorter Healing After Endoscopic Pilonidal Sinus Treatment

Negative Pressure Therapy Linked to Shorter Healing After Endoscopic Pilonidal Sinus Treatment

November 17, 2026

Combining Remimazolam with Propofol Lowers Dose Requirements but Alters Recovery Dynamics

November 17, 2026

Young People in Southern Ethiopia Show High Acceptability of HIV Self-Testing

November 17, 2026

POPULAR NEWS

  • Structured IDEA Expert Elicitation Framework Enhances Design of Rare Disease Trials

    Structured IDEA Expert Elicitation Framework Enhances Design of Rare Disease Trials

    29 shares
    Share 12 Tweet 7
  • Syndesmotic Fixation Speeds Early Ankle Recovery but Matches Non-Fixation at Two Years

    29 shares
    Share 12 Tweet 7
  • German Nationwide Survey Identifies Workplace Bullying Patterns Across Industries and Age Groups

    29 shares
    Share 12 Tweet 7
  • TCAD Simulations Identify Efficiency Gains for Sustainable CZTS Solar Cells

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

7T MRI Feasibility Study Maps Diffuse Lipid Alterations in Multiple Sclerosis

Negative Pressure Therapy Linked to Shorter Healing After Endoscopic Pilonidal Sinus Treatment

Combining Remimazolam with Propofol Lowers Dose Requirements but Alters Recovery Dynamics

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.